Discontinuation report PHENYLEPHRINE HYDROCHLORIDE INJECTION USP

Last updated on 2024-08-08 History
Report ID 223140
Drug Identification Number 02504545
Brand name PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
Common or Proper name PHENYLEPHRINE HYDROCHLORIDE INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) PHENYLEPHRINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 25 VIALS 1 ML
ATC code C01CA
ATC description CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2024-03-22
Actual discontinuation date 2024-07-30
Remaining supply date 2024-03-22
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Product will no longer be available upon the depletion of inventory at the wholesalers.
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2024-08-08 French Compare
v3 2024-08-08 English Compare
v2 2024-03-22 French Compare
v1 2024-03-22 English Compare

Showing 1 to 4 of 4